Review article · 23 Sep 2025
EditorialPublished 22 Sep 2016
Recent Advances in Hodgkin Lymphoma
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hodgkin lymphoma (HL) is considered as a highly curable malignancy, but successful treatment can be associated with significant long-term toxicity. Traditional treatment modalities include chemotherapy, radiotherapy (RT) and salvage chemotherapy with autologous stem cell transplantation (ASCT). The goal of modern treatment is focused on tailoring each patient’s approach according to age, risk of relapse and risk of short- and long-term toxicity.
Keywords
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Blood Research & Hematologic Diseases.
Commentary · 16 Apr 2025
Chronic Bleeding Conditions: Evaluating Risk Factors and Treatment Approaches
Commentary · 17 Mar 2025
Blood Disorders and Their Systemic Effects on Health
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood Research & Hematologic Diseases
- SubjectHaematology
- BylineArticles whose byline prints “Theodoros P Vassilakopoulos”
- BylineArticles whose byline prints “Sotirios G Papageorgiou”

